Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors

Behavioural Brain Research

Volumn 256, Issue , 2013, Pages 451-456

  Réus, Gislaine Z ^a   Abelaira, Helena M ^a   dos Santos, Maria Augusta B ^a   Carlessi, Anelise S ^a   Tomaz, Débora B ^a   Neotti, Morgana V ^a   Liranço, João Lucas G ^a   Gubert, Carolina ^b   Barth, Maurício ^b   Kapczinski, Flávio ^b   Quevedo, João ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Behavior; Depression; Histone deacetylation; Maternal deprivation

Indexed keywords

HISTONE DEACETYLASE; IMIPRAMINE; KETAMINE; SODIUM CHLORIDE;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; FEMALE; FORCED SWIMMING TEST; HIPPOCAMPUS; HISTONE ACETYLATION; HISTONE DEACETYLATION; IMMOBILITY; MALE; MATERNAL DEPRIVATION; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

BEHAVIOR; DEPRESSION; HDAC; HISTONE DEACETYLASE; HISTONE DEACETYLATION; MATERNAL DEPRIVATION; N-METHYL-D-ASPARTE; NMDA;

ACETYLATION; AMYGDALA; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; HIPPOCAMPUS; HISTONES; IMIPRAMINE; KETAMINE; MALE; MATERNAL DEPRIVATION; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SWIMMING;

EID: 84884388065     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.08.041     Document Type: Article

References (54)

1. Holmes A., le Guisquet A.M., Vogel E., Millstein R.A., Leman S., Belzung C. Early life genetic, epigenetic, and environmental factors shaping emotionality in rodents. Neurosci Biobehav Rev 2005, 29:1335-1346.
2. Afifi T.O., Enns M.W., Cox B.J., Asmundson G.J.G., Stein M.B., Sareen J. Population attributable fractions of psychiatric disorders and suicide ideation and attempts associated with adverse childhood experiences. Am J Public Health 2008, 98:946-952.
3. Green J.G., McLaughlin K.A., Berglund P.A., Gruber M.J., Sampson N.A., Zaslavsky A.M., et al. Childhood adversities and adult psychiatric disorders in the National Comorbidity Survey Replication I: associationswith first onset of DSM-IV disorders. Arch Gen Psychiatry 2010, 67:113-123.
4. Levine A., Worrell T.R., Zimnisky R., Schmauss C. Early life stress triggers sustained changes in histone deacetylase expression and histone H4 modifications thatalter responsiveness to adolescent antidepressant treatment. Neurobiol Dis 2012, 45:488-498.
5. Sanacora G., Zarate C.A., Krystal J.H., et al. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev 2008, 7:426-437.
6. Zarate C.A., Manji H.K. The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases. Clin Exp Neurol 2008, 211:7-10.
7. Autry A.E., Adachi M., Nosyreva E., Na E.S., Los M.F., Cheng P.F., et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011, 475:91-95.
8. Garcia L.S., Comim C.M., Valvassori S.S., et al. Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:450-455.
9. Lee H., Rezai-Zadeh N., Seto E. Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A. Mol Cell Biol 2004, 24:765-773.
10. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., Nestler E.J. Sustained hippocampal chromatine regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006, 9:519-525.
11. Covington H.E., Maze I., LaPlant Q.C., Vialou V.F., Ohnishi Y.N., Berton O., et al. Antidepressant actions of histone deacetylase inhibitors. J Neurosci 2009, 29:11451-11460.
12. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001, 11:240-249.
13. Charney D.S., Manji H.K. Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE 2004, 225:re5.
14. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
15. Langley B., Gensert J.M., Beal M.F., Ratan R.R. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr Drug Targets 2005, 4:41-50.
16. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004, 7:847-854.
17. Kosten T.A., Lee H.J., Kim J.J. Neonatal handling alters learning in adult male and female rats in a task-specific manner. Brain Res 2007, 18:144-153.
18. Mello P.B. Physical exercise can reverse the deficit in fear memory induced by maternal deprivation. Neurobiol Learn Mem 2009, 92:364-369.
19. Abelaira H.M., Réus G.Z., Ribeiro K.F., Zappellini G., Cipriano A.L., Scaini G., et al. Lamotrigine treatment reverses depressive-like behavior and alters BDNF levels in the brains of maternally deprived adult rats. Pharmacol Biochem Behav 2012, 101:348-353.
20. Fortunato J.J., Réus G.Z., Kirsch T.R., Stringari R.B., Fries G.R., Kapczinski F., et al. Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus. J Neural Transm 2010, 117:1131-1137.
21. Réus G.Z., Stringari R.B., Ribeiro K.F., Ferraro A.K., Vitto M.F., Cesconetto P., et al. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res 2011, 221:166-171.
22. Garcia L.S., Comim C.M., Valvassori S.S., Réus G.Z., Barbosa L.M., Andreazza A.C., et al. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 2008, 321:140-144.
23. Garcia L.S., Comim C.M., Valvassori S.S., Réus G.Z., Andreazza A.C., Stertz L., et al. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Basic Clin Pharmacol Toxicol 2008, 103:502-506.
24. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
25. Porsolt R.D., Le Pichon M., Jalfre M. Animal model of depression. Nature 1977, 266:730-732.
26. Paxinos G., Watson C. The Rat Brain: Stereotaxic Coordinates 1986, Academic Press, Australia. Second ed.
27. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
28. Heim C., Owens M.J., Plotsky P.M., Nemeroff C.B. Persistent changes in corticotrophin-releasing factor system due to early life stress: relationship to the pathophysiology of major depression and post-traumatic stress disorder. Psychopharmacol Bull 1997, 33:185-192.
29. Ladd C.O., Huot R.L., Thrivikraman K.V., Nemeroff C.B., Meaney M.J., Plotsky P.M. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog Brain Res 2000, 122:81-103.
30. Daniels W.M., Pietersen C.Y., Carstens M.E., Stein D.J. Maternal separation in rats leads to anxiety-like behavior and a blunted ACTH response and altered neurotransmitter levels in response to a subsequent stressor. Metab Brain Dis 2004, 19:3-14.
31. El Khoury A., Gruber S.H.M., Mork A., Mathe A.A. Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:533-540.
32. Réus G.Z., Dos Santos M.A., Abelaira H.M., Ribeiro K.F., Petronilho F., Vuolo F., et al. Imipramine reverses alterations in cytokines and BDNF levels induced by maternal deprivation in adult rats. Behav Brain Res 2013, 242:40-46.
33. Aisa B., Tordera R., Lasheras B., Del Río J., Ramírez M.J. Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats. Psychoneuroendocrinology 2007, 32:256-266.
34. Réus G.Z., Stringari R.B., Ribeiro K.F., Cipriano A.L., Panizzutti B.S., Stertz L., et al. Maternal deprivation induces depressive-like behaviour and alters neurotrophin levels in the rat brain. Neurochem Res 2011, 363:460-466.
35. Ceretta L.B., Réus G.Z., Stringari R.B., Ribeiro K.F., Zappellini G., Aguiar B.W., et al. Imipramine treatment reverses depressive-like behavior in alloxan-diabetic rats. Diabetes Metab Res Rev 2012, 28:139-144.
36. Collin M., Hakansson-Ovesjo M.L., Misane I., Ogren S.O., Meister B. Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. Brain Res Mol Brain Res 2000, 81:51-61.
37. Crawley J.N., Belknap J.K., Collins A., et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 1997, 132:107-124.
38. Akillioglu K., Melik E.B., Melik E., Boga A. Effect of ketamine on exploratory behaviour in BALB/C and C57BL/6 mice. Pharmacol Biochem Behav 2012, 100:513-517.
39. Duncan G.E., Moy S.S., Knapp D.J., Mueller R.A., Breese G.R. Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res 1998, 787:181-190.
40. Laprade N., Soghomonian J.J. MK-801 decreases striatal and cortical GAD65 mRNA levels. Neuroreport 1995, 6:1885-1889.
41. Löscher W., Hönack D. The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur J Pharmacol 1992, 215:199-208.
42. Yamamoto M., Mizuki Y., Suetsugi M., Ozawa Y., Ooyama M., Suzuki M. Effects of dopamine antagonists on changes in spontaneous EEG and locomotor activity in ketamine-treated rats. Pharmacol Biochem Behav 1997, 57:361-365.
43. Renthal W., Nestler E.J. Epigenetic mechanisms in drug addiction. Trends Mol Med 2008, 14:341-350.
44. Ookubo M., Kanai H., Aoki H., Yamada N. Antidepressants and mood stabilizers effects on histone deacetylase expression in C57BL/6 mice: brain regionspecific changes. J Psychiatr Res 2013, 47:1204-1214.
45. Mao X., Hou T., Cao B., Wang W., Li Z., Chen S., et al. The tricyclic antidepressant amitriptyline inhibits d-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidence. Mol Pharmacol 2011, 79:672-680.
46. Hobara T., Uchida S., Otsuki K., Matsubara T., Funato H., Matsuo K., et al. Altered gene expression of histone deacetylases in mood disorder patients. J Psychiatr Res 2010, 44:263-270.
47. Gottlicher M., Minucci S., Zhu P., et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001, 20:6969-6978.
48. Willner P. Dopamine and depression: a review of recent evidence. II. Theoretical approaches. Brain Res 1983, 287:225-236.
49. Zacharko R.M., Anisman H. Stressor-induced anhedonia in the mesocorticolimbic system. Neurosci Biobehav Rev 1991, 15:391-405.
50. Willner P., Muscat R., Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 1992, 16:525-534.
51. Wise R.A. The role of reward pathways in the development of drug dependence. Pharmacol Ther 1987, 35:227-263.
52. Koob G.F. Hedonic valence, dopamine and motivation. Mol Psychiatry 1996, 1:186-189.
53. Carelli R.M. The nucleus accumbens and reward: neurophysiological investigations in behaving animals. Behav Cogn Neurosci Rev 2002, 1:281-296.
54. Archer T., Oscar-Berman M., Blum K., Gold M. Epigenetic modulation of mood disorders. J Genet Syndr Gene Ther 2013, 4(120). pii: 1000120.